Stent Expansion as a Mechanical Parameter to Predict Late Stent Patency. Back to the Basics

JACC: Cardiovascular Interventions

Volumn 2, Issue 12, 2009, Pages 1276-1278

  Honda, Yasuhiro ^a   Fitzgerald, Peter J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

drug eluting stent; intravascular ultrasound; restenosis; stent expansion

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ARTERY INTIMA PROLIFERATION; BARE METAL STENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DRUG ELUTING STENT; EDITORIAL; EQUIPMENT DESIGN; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; MEDICAL PARAMETERS; PREDICTION; PRIORITY JOURNAL; STENT EXPANSION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; HUMANS; METALS; MODELS, STATISTICAL; PREDICTIVE VALUE OF TESTS; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; STENTS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL; VASCULAR PATENCY;

EID: 72149085728     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2009.10.013     Document Type: Editorial

References (14)

1. Honda Y., Fitzgerald P.J., and Yock P.G. Intravascular ultrasound. In: Topol E.J. (Ed). Textbook of Interventional Cardiology. 5th edition (2007), Saunders Elsevier, Philadelphia, PA 1115-1142
2. Mudra H., di Mario C., de Jaegere P., et al. Randomized comparison of coronary stent implantation under ultrasound or angiographic guidance to reduce stent restenosis (OPTICUS study). Circulation 104 (2001) 1343-1349
3. Orford J.L., Denktas A.E., Williams B.A., et al. Routine intravascular ultrasound scanning guidance of coronary stenting is not associated with improved clinical outcomes. Am Heart J 148 (2004) 501-506
4. Hoffmann R., Mintz G.S., Dussaillant G.R., et al. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation 94 (1996) 1247-1254
5. Mintz G.S., Popma J.J., Hong M.K., et al. Intravascular ultrasound to discern device-specific effects and mechanisms of restenosis. Am J Cardiol 78 (1996) 18-22
6. Honda Y. Drug-eluting stents. Insights from invasive imaging technologies. Circ J 73 (2009) 1371-1380
7. Doi H., Maehara A., Mintz G.S., et al. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent trials. J Am Coll Cardiol Intv 2 (2009) 1269-1275
8. Hong M.K., Mintz G.S., Lee C.W., et al. Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation. Eur Heart J 27 (2006) 1305-1310
9. Morino Y., Honda Y., Okura H., et al. An optimal diagnostic threshold for minimal stent area to predict target lesion revascularization following stent implantation in native coronary lesions. Am J Cardiol 88 (2001) 301-303
10. Okumura M., Ozaki Y., Ishii J., et al. Restenosis and stent fracture following sirolimus-eluting stent (SES) implantation. Circ J 71 (2007) 1669-1677
11. Sonoda S., Morino Y., Ako J., et al. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the SIRIUS trial. J Am Coll Cardiol 43 (2004) 1959-1963
12. Castagna M.T., Mintz G.S., Leiboff B.O., et al. The contribution of "mechanical" problems to in-stent restenosis: an intravascular ultrasonographic analysis of 1090 consecutive in-stent restenosis lesions. Am Heart J 142 (2001) 970-974
13. Fujii K., Mintz G.S., Kobayashi Y., et al. Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis. Circulation 109 (2004) 1085-1088
14. Honda Y., and Fitzgerald P.J. Stent thrombosis: an issue revisited in a changing world. Circulation 108 (2003) 2-5